EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity

Farha Naz, Md Jashim Uddin, Nicholas Hagspiel, Mary K Young, David Tyus, Rachel Boone, Audrey C Brown, Girija Ramakrishnan, Isaura Rigo, Claire Fleming, Gregory R Madden, William A Petri

Journal of Clinical Investigation · 2025

DOI: 10.1172/jci184659 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2025. Verfasst von Farha Naz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases and International Health. Hauptthemen laut MEDLINE: Interleukin-33, Immunity, Humoral, Clostridioides difficile, Clostridium Infections. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, National institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Clostridioides difficile infection (CDI) recurs in 1 of 5 patients. Monoclonal antibodies targeting the virulence factor TcdB reduce disease recurrence, suggesting that an inadequate anti-TcdB response to CDI leads to recurrence. In patients with CDI, we discovered that IL-33 measured at diagnosis predicts future recurrence, leading us to test the role of IL-33 signaling in the induction of humoral immunity during CDI. Using a mouse recurrence model, IL-33 was demonstrated to be integral for anti-TcdB antibody production. IL-33 acted via ST2 + ILC2 cells, facilitating germinal center T follicular helper (GC-Tfh) cell generation of antibodies. IL-33 protection from reinfection was antibody-dependent, as μMT KO mice and mice treated with anti-CD20 mAb were not protected. These findings demonstrate the critical role of IL-33 in generating humoral immunity to prevent recurrent CDI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-33Immunity, HumoralClostridioides difficileClostridium InfectionsAnimalsMiceMice, KnockoutHumansFemaleBacterial ProteinsAntibodies, BacterialRecurrenceMaleInterleukin-1 Receptor-Like 1 ProteinT Follicular Helper CellsBacterial Toxins

Stichwörter der Autor:innen

Adaptive immunityImmunologyInfectious disease

Substanzen

Interleukin-33Il33 protein, mouseIL33 protein, humanBacterial ProteinsAntibodies, BacterialInterleukin-1 Receptor-Like 1 ProteinIl1rl1 protein, mousetoxB protein, Clostridium difficileBacterial Toxins

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases and International Health.
  • Department of Microbiology, Immunology, and Cancer Biology, and.
  • Department of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • National institutes of Health

Zitieren

APA

Naz, F., Uddin, M. J., Hagspiel, N., Young, M. K., Tyus, D., Boone, R., Brown, A. C., Ramakrishnan, G., Rigo, I., Fleming, C., Madden, G. R., & Petri, W. A. (2025). IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity. Journal of Clinical Investigation. https://doi.org/10.1172/jci184659

Vancouver

Naz F, Uddin MJ, Hagspiel N, Young MK, Tyus D, Boone R, et al. IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity. Journal of Clinical Investigation. 2025. doi:10.1172/jci184659

BibTeX
@article{Naz2025,
  author = {Naz, Farha and Uddin, Md Jashim and Hagspiel, Nicholas and Young, Mary K and Tyus, David and Boone, Rachel and Brown, Audrey C and Ramakrishnan, Girija and Rigo, Isaura and Fleming, Claire and Madden, Gregory R and Petri, William A},
  title = {IL-33 protects from recurrent C. difficile infection by restoration of humoral immunity},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci184659}
}
Kostenlos starten →